Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sergey Gamayunov"'
Autor:
Arseniy Potapov, Lev Matveev, Alexander Moiseev, Elena Sedova, Maria Loginova, Maria Karabut, Irina Kuznetsova, Viktoriya Levchenko, Elena Grebenkina, Sergey Gamayunov, Stefka Radenska-Lopovok, Marina Sirotkina, Natalia Gladkova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 18, p 13967 (2023)
Photodynamic therapy (PDT) is a modern treatment for severe or treatment-resistant vulvar lichen sclerosus (VLS). The chronic and recurrent nature of VLS requires control of recurrences at an early stage. In this paper, a non-invasive multimodal opti
Externí odkaz:
https://doaj.org/article/dc6ccdf704b04212b27ed955a2ec8728
Autor:
Natalia Dengina, Timur Mitin, Sergey Gamayunov, Sufia Safina, Yuliya Kreinina, Ilya Tsimafeyeu
Publikováno v:
ESMO Open, Vol 4, Iss 5 (2019)
Background Tyrosine kinase inhibitors (TKIs) and checkpoint inhibitors have been established as effective treatment for metastatic renal cell carcinoma (mRCC), but only a minority of patients achieve complete response. Additional strategies are neces
Externí odkaz:
https://doaj.org/article/541676ecaac74a43be18b600eb3890a0
Autor:
Ekaterina Gubarkova, Elena Kiseleva, Alexander Moiseev, Dmitry Vorontsov, Sergey Kuznetsov, Anton Plekhanov, Maria Karabut, Marina Sirotkina, Grigory Gelikonov, Sergey Gamayunov, Alexey Vorontsov, Petr Krivorotko, Natalia Gladkova
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2663
Intraoperative differentiation of tumorous from non-tumorous tissue can help in the assessment of resection margins in breast cancer and its response to therapy and, potentially, reduce the incidence of tumor recurrence. In this study, the calculatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41970f6a2829f656d3d05e4da87aba93
https://doi.org/10.3390/cancers15092663
https://doi.org/10.3390/cancers15092663
Autor:
Yuliya Kreinina, Natalia Dengina, Ilya Tsimafeyeu, Sufia Safina, Timur Mitin, Sergey Gamayunov
Publikováno v:
ESMO Open, Vol 4, Iss 5 (2019)
ESMO Open
ESMO Open
Background Tyrosine kinase inhibitors (TKIs) and checkpoint inhibitors have been established as effective treatment for metastatic renal cell carcinoma (mRCC), but only a minority of patients achieve complete response. Additional strategies are neces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ab7af276386e0e9639ca914a29965a
https://esmoopen.bmj.com/content/4/5/e000535.full
https://esmoopen.bmj.com/content/4/5/e000535.full
Autor:
Dmitry Kosov, Andrey Semenov, Sergey Gamayunov, Olga Novikova, Irina Sivunova, Ahmed Abdelgafur, Madina Ramazanova, Irina Guseva, Nadezhda Mikhailova, Ilya Tsimafeyeu, Marina Demchenkova, Gennady Bratslavsky, Roman Leonenkov, Zakhar Yurmazov, Pavel Borisov
Publikováno v:
Targeted oncology. 14(1)
Targeted therapy with axitinib resulted in a greater objective response rate and prolonged progression-free survival (PFS) compared to sorafenib in patients with previously treated metastatic renal cell carcinoma (mRCC) in the phase 3 AXIS study, whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ab228f1a5fdbeab8b50206779ab6d
https://pubmed.ncbi.nlm.nih.gov/30607698
https://pubmed.ncbi.nlm.nih.gov/30607698
Autor:
Varvara V. Dudenkova, Anna A. Brilkina, S.S. Kuznetsov, Sergey Gamayunov, Natalia M. Shakhova
Publikováno v:
Biomedical Optics 2016.
Capabilities of multiphoton microscopy for investigation of Photoditazin distribution in tumor cell line and in ex vivo human tumor is demonstrated. The preferential accumulation of PS in the stroma compared with cellular component is shown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f76d7e1f633adef048cc0addd9c80e9
https://doi.org/10.1364/cancer.2016.jm3a.38
https://doi.org/10.1364/cancer.2016.jm3a.38
Autor:
Zakhar Yurmazov, Roman Leonenkov, Madina Ramazanova, Sergey Gamayunov, Dmitry Kosov, Irina Guseva, Nadezhda Mikhailova, Marina Demchenkova, Irina Sivunova, Ahmed Abdelgafur, Ilya Tsimafeyeu, Pavel Borisov, Andrey Semenov, Olga Novikova
Publikováno v:
Journal of Clinical Oncology. 36:666-666
666 Background: Targeted therapy with axitinib resulted in a greater objective response rate and prolonged progression-free survival (PFS) compared to sorafenib in patients with previously treated metastatic renal cell carcinoma (mRCC) in AXIS study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7926d95318a42f3fe7d061484662e48
https://doi.org/10.1200/jco.2018.36.6_suppl.666
https://doi.org/10.1200/jco.2018.36.6_suppl.666
Autor:
Sergey Gamayunov, Onoprienko, O. V., Slugaryov, V. V., Denisenko, A. N., Gutakovskaya, N. V., Illarionova, N. A.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::05a7f8c81ee4e243a768ecdbcb7da850
http://www.scopus.com/inward/record.url?eid=2-s2.0-84872507827&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84872507827&partnerID=MN8TOARS
